Fig 1: The assessment of myrrh essential oil (50 and 100 mg/kg) administration for three weeks prior to renal ischemia/perfusion (I/R) through the renal function tests: (a) creatinine, (b) BUN, (c) uric acid, (d) LDL; renal injury biomarkers: (e) Kim-1, (f) NGAL, and (g) CysC. All values are expressed as mean ± SD. # indicates a statistically significant difference from the sham group, € indicates a statistically significant difference from the renal I/R group, and ¥ indicates a statistically significant difference from myrrh 50 mg/kg + renal I/R group (p < 0.05) using one-way ANOVA followed by Turkey’s post hoc test (n = 6).
Supplier Page from Abcam for Rat Cystatin C ELISA Kit